DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Zaki M, Hairat S, Aazam ES.
Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.
RSC Advances 2019;
9 (06) 3239-3278
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.